Cargando…

Exploring Contraindications for Thrombolysis: Risk of Hemorrhagic Transformation and Neurological Deterioration after Thrombolysis in Mice with Recent Ischemic Stroke and Hyperglycemia

(1) Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) in patients with acute ischemic stroke is limited because of several contraindications. In routine clinical practice, patients with a recent stroke are typically not treated with rt-PA in case of a recurrent ischemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelhard, Sarah, Kestner, Roxane-Isabelle, Armbrust, Moritz, Steinmetz, Helmuth, Foerch, Christian, Bohmann, Ferdinand O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225099/
https://www.ncbi.nlm.nih.gov/pubmed/35743425
http://dx.doi.org/10.3390/jcm11123343
_version_ 1784733536325992448
author Gelhard, Sarah
Kestner, Roxane-Isabelle
Armbrust, Moritz
Steinmetz, Helmuth
Foerch, Christian
Bohmann, Ferdinand O.
author_facet Gelhard, Sarah
Kestner, Roxane-Isabelle
Armbrust, Moritz
Steinmetz, Helmuth
Foerch, Christian
Bohmann, Ferdinand O.
author_sort Gelhard, Sarah
collection PubMed
description (1) Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) in patients with acute ischemic stroke is limited because of several contraindications. In routine clinical practice, patients with a recent stroke are typically not treated with rt-PA in case of a recurrent ischemic event. The same applies to its use in the context of pulmonary artery embolism and myocardial infarction with a recent stroke. In this translational study, we evaluated whether rt-PA treatment after experimental ischemic stroke with or without additional hyperglycemia increases the risk for hemorrhagic transformation (HT) and worsens functional outcome regarding the old infarct area. (2) In total, 72 male C57BL/6N mice were used. Ischemic stroke (index stroke) was induced by transient middle cerebral artery occlusion (tMCAO). Mice received either rt-PA or saline 24 h or 14 days after index stroke to determine whether a recent ischemic stroke predisposes to HT. In addition to otherwise healthy mice, hyperglycemic mice were analyzed to evaluate diabetes as a second risk factor for HT. Mice designated to develop hyperglycemia were pre-treated with streptozotocin. (3) The neurological outcome in rt-PA and saline-treated normoglycemic mice did not differ significantly, either at 24 h or at 14 days. In contrast, hyperglycemic mice treated with rt-PA had a significantly worse neurological outcome (at 24 h, p = 0.02; at 14 days, p = 0.03). At 24 h after rt-PA or saline treatment, HT scores differed significantly (p = 0.02) with the highest scores within hyperglycemic mice treated with rt-PA, where notably only small petechial hemorrhages could be detected. (4) Thrombolysis after recent ischemic stroke does not increase the risk for HT or worsen the functional outcome in otherwise healthy mice. However, hyperglycemia as a second risk factor leads to neurological deterioration after rt-PA treatment, which cannot be explained by an increase of HT alone. Direct neurotoxic effects of rt-PA may play a role.
format Online
Article
Text
id pubmed-9225099
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92250992022-06-24 Exploring Contraindications for Thrombolysis: Risk of Hemorrhagic Transformation and Neurological Deterioration after Thrombolysis in Mice with Recent Ischemic Stroke and Hyperglycemia Gelhard, Sarah Kestner, Roxane-Isabelle Armbrust, Moritz Steinmetz, Helmuth Foerch, Christian Bohmann, Ferdinand O. J Clin Med Article (1) Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) in patients with acute ischemic stroke is limited because of several contraindications. In routine clinical practice, patients with a recent stroke are typically not treated with rt-PA in case of a recurrent ischemic event. The same applies to its use in the context of pulmonary artery embolism and myocardial infarction with a recent stroke. In this translational study, we evaluated whether rt-PA treatment after experimental ischemic stroke with or without additional hyperglycemia increases the risk for hemorrhagic transformation (HT) and worsens functional outcome regarding the old infarct area. (2) In total, 72 male C57BL/6N mice were used. Ischemic stroke (index stroke) was induced by transient middle cerebral artery occlusion (tMCAO). Mice received either rt-PA or saline 24 h or 14 days after index stroke to determine whether a recent ischemic stroke predisposes to HT. In addition to otherwise healthy mice, hyperglycemic mice were analyzed to evaluate diabetes as a second risk factor for HT. Mice designated to develop hyperglycemia were pre-treated with streptozotocin. (3) The neurological outcome in rt-PA and saline-treated normoglycemic mice did not differ significantly, either at 24 h or at 14 days. In contrast, hyperglycemic mice treated with rt-PA had a significantly worse neurological outcome (at 24 h, p = 0.02; at 14 days, p = 0.03). At 24 h after rt-PA or saline treatment, HT scores differed significantly (p = 0.02) with the highest scores within hyperglycemic mice treated with rt-PA, where notably only small petechial hemorrhages could be detected. (4) Thrombolysis after recent ischemic stroke does not increase the risk for HT or worsen the functional outcome in otherwise healthy mice. However, hyperglycemia as a second risk factor leads to neurological deterioration after rt-PA treatment, which cannot be explained by an increase of HT alone. Direct neurotoxic effects of rt-PA may play a role. MDPI 2022-06-10 /pmc/articles/PMC9225099/ /pubmed/35743425 http://dx.doi.org/10.3390/jcm11123343 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gelhard, Sarah
Kestner, Roxane-Isabelle
Armbrust, Moritz
Steinmetz, Helmuth
Foerch, Christian
Bohmann, Ferdinand O.
Exploring Contraindications for Thrombolysis: Risk of Hemorrhagic Transformation and Neurological Deterioration after Thrombolysis in Mice with Recent Ischemic Stroke and Hyperglycemia
title Exploring Contraindications for Thrombolysis: Risk of Hemorrhagic Transformation and Neurological Deterioration after Thrombolysis in Mice with Recent Ischemic Stroke and Hyperglycemia
title_full Exploring Contraindications for Thrombolysis: Risk of Hemorrhagic Transformation and Neurological Deterioration after Thrombolysis in Mice with Recent Ischemic Stroke and Hyperglycemia
title_fullStr Exploring Contraindications for Thrombolysis: Risk of Hemorrhagic Transformation and Neurological Deterioration after Thrombolysis in Mice with Recent Ischemic Stroke and Hyperglycemia
title_full_unstemmed Exploring Contraindications for Thrombolysis: Risk of Hemorrhagic Transformation and Neurological Deterioration after Thrombolysis in Mice with Recent Ischemic Stroke and Hyperglycemia
title_short Exploring Contraindications for Thrombolysis: Risk of Hemorrhagic Transformation and Neurological Deterioration after Thrombolysis in Mice with Recent Ischemic Stroke and Hyperglycemia
title_sort exploring contraindications for thrombolysis: risk of hemorrhagic transformation and neurological deterioration after thrombolysis in mice with recent ischemic stroke and hyperglycemia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225099/
https://www.ncbi.nlm.nih.gov/pubmed/35743425
http://dx.doi.org/10.3390/jcm11123343
work_keys_str_mv AT gelhardsarah exploringcontraindicationsforthrombolysisriskofhemorrhagictransformationandneurologicaldeteriorationafterthrombolysisinmicewithrecentischemicstrokeandhyperglycemia
AT kestnerroxaneisabelle exploringcontraindicationsforthrombolysisriskofhemorrhagictransformationandneurologicaldeteriorationafterthrombolysisinmicewithrecentischemicstrokeandhyperglycemia
AT armbrustmoritz exploringcontraindicationsforthrombolysisriskofhemorrhagictransformationandneurologicaldeteriorationafterthrombolysisinmicewithrecentischemicstrokeandhyperglycemia
AT steinmetzhelmuth exploringcontraindicationsforthrombolysisriskofhemorrhagictransformationandneurologicaldeteriorationafterthrombolysisinmicewithrecentischemicstrokeandhyperglycemia
AT foerchchristian exploringcontraindicationsforthrombolysisriskofhemorrhagictransformationandneurologicaldeteriorationafterthrombolysisinmicewithrecentischemicstrokeandhyperglycemia
AT bohmannferdinando exploringcontraindicationsforthrombolysisriskofhemorrhagictransformationandneurologicaldeteriorationafterthrombolysisinmicewithrecentischemicstrokeandhyperglycemia